Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 8Myeloproliferative Disorders 3Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Myelodysplastic Syndromes 1Leukemia, Monocytic, Acute 1

Interventions

Injections 3Cytarabine 3Biopsy 3pegylated granulocyte colony-stimulating factor 2Whole-Body Irradiation 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Decitabine 2Daunorubicin 2Cyclophosphamide 2Cladribine 2Azacitidine 2venetoclax 1ruxolitinib 1fludarabine phosphate 1fludarabine 1fedratinib 1enasidenib 1Thiotepa 1Spinal Puncture 1Specimen Handling 1Sirolimus 1Mycophenolic Acid 1Mitoxantrone 1Methotrexate 1Liposomes 1Gemtuzumab 1Cyclosporins 1Cyclosporine 1CPX-351 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Monocytic, Acute × Liposomes × 90 days × Clear all
NCT04195945 2026-05-14

CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
60 enrolled 19 charts
Other hematologic neoplasm

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡